SO-008Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study. (2nd July 2019) - Saleh, M; Cassier, P; Eberst, L; Naik, G; II, V Morris; Pant, S; Terret, C; Gao, L; Long, A; Mao, H; McNeely, S; Carlesi, R; et al.